05/15/2024
8:16 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:47 AM | Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:49 AM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:51 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:13 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:20 PM | Nuvectis Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/05/2024
7:17 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
7:37 AM | Mosseri Marlio Charles (Filed by)
Nuvectis Pharma (Subject)
| Form SC 13G/A | |
02/06/2024
7:47 AM | Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
| Form SC 13G | |
01/30/2024
8:01 PM | Nuvectis Pharma (Subject)
Peters Thomas Phineas (Filed by)
| Form SC 13G/A | |
01/05/2024
3:30 PM | Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:31 PM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:39 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:45 AM | Nuvectis Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/12/2023
3:05 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
7:30 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
7:37 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
7:16 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
8:18 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
5:07 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2023
5:52 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:45 PM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:45 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
5:30 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
5:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
7:06 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
7:34 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
7:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
7:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:03 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:04 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
6:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
7:00 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
7:45 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
7:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
7:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Top 5 Tech Stocks to Buy for 2024 (Ad) The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", |
06/23/2023
7:59 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:42 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:25 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:15 AM | Hoberman Kenneth (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:16 AM | Kaplan Matthew L. (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:16 AM | Nuvectis Pharma (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:45 PM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
5:46 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
